BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29784059)

  • 21. Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial.
    Johansen MY; Karstoft K; MacDonald CS; Hansen KB; Ellingsgaard H; Hartmann B; Wewer Albrechtsen NJ; Vaag AA; Holst JJ; Pedersen BK; Ried-Larsen M
    Diabetologia; 2020 Nov; 63(11):2410-2422. PubMed ID: 32816096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of an 8-Year Intensive Lifestyle Intervention on an Index of Multimorbidity.
    Espeland MA; Gaussoin SA; Bahnson J; Vaughan EM; Knowler WC; Simpson FR; Hazuda HP; Johnson KC; Munshi MN; Coday M; Pi-Sunyer X
    J Am Geriatr Soc; 2020 Oct; 68(10):2249-2256. PubMed ID: 33267558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of digital health using the transtheoretical model to prevent or delay type 2 diabetes in impaired glucose tolerance patients: protocol for a randomized control trial.
    Alzeidan R; Shata Z; Hassounah MM; Baghdadi LR; Hersi A; Fayed A; Kashour T; Elmorshedy H
    BMC Public Health; 2019 Nov; 19(1):1550. PubMed ID: 31752774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a Shared Medical Appointment Lifestyle Intervention on Weight and Lipid Parameters in Individuals with Type 2 Diabetes: A Clinical Pilot.
    Guthrie GE; Bogue RJ
    J Am Coll Nutr; 2015; 34(4):300-9. PubMed ID: 25757855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized wait-list control trial to evaluate the impact of a mobile application to improve self-management of individuals with type 2 diabetes: a study protocol.
    Desveaux L; Agarwal P; Shaw J; Hensel JM; Mukerji G; Onabajo N; Marani H; Jamieson T; Bhattacharyya O; Martin D; Mamdani M; Jeffs L; Wodchis WP; Ivers NM; Bhatia RS
    BMC Med Inform Decis Mak; 2016 Nov; 16(1):144. PubMed ID: 27842539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist-led therapeutic carbohydrate restriction as a treatment strategy for type 2 diabetes: the Pharm-TCR randomized controlled trial protocol.
    Durrer C; McKelvey S; Singer J; Batterham AM; Johnson JD; Wortman J; Little JP
    Trials; 2019 Dec; 20(1):781. PubMed ID: 31881991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Diabetes Remission in India (DiRemI) study: Protocol for a prospective matched-control trial.
    Tripathi P; Kadam N; Tiwari D; Kathrikolly T; Vyawahare A; Sharma B; Ganla M; Saboo B
    PLoS One; 2024; 19(6):e0306394. PubMed ID: 38941311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic medical assessment, referral and treatment for diabetes care in China using lay family health promoters: protocol for the SMARTDiabetes cluster randomised controlled trial.
    Peiris D; Sun L; Patel A; Tian M; Essue B; Jan S; Zhang P
    Implement Sci; 2016 Aug; 11(1):116. PubMed ID: 27535128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial.
    Miklavcic JJ; Fraser KD; Ploeg J; Markle-Reid M; Fisher K; Gafni A; Griffith LE; Hirst S; Sadowski CA; Thabane L; Triscott JAC; Upshur R
    BMC Geriatr; 2020 May; 20(1):174. PubMed ID: 32404059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year caloric restriction and 12-week exercise training intervention in obese adults with type 2 diabetes: emphasis on metabolic control and resting metabolic rate.
    Zurlo F; Trevisan C; Vitturi N; Ravussin E; Salvò C; Carraro S; Siffi M; Iob I; Saller A; Previato L; Sergi G; de Kreutzenberg S; Maran A; Avogaro A
    J Endocrinol Invest; 2019 Dec; 42(12):1497-1507. PubMed ID: 31359403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Lifestyle Intervention for the Treatment of Diabetes study (LIFT Diabetes): Design and baseline characteristics for a randomized translational trial to improve control of cardiovascular disease risk factors.
    Katula JA; Kirk JK; Pedley CF; Savoca MR; Effoe VS; Bell RA; Bertoni AG;
    Contemp Clin Trials; 2017 Feb; 53():89-99. PubMed ID: 27940180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol.
    Suleiman N; Alkasem M; Al Amer Z; Salameh O; Al-Thani N; Hamad MK; Baagar K; Abdalhakam I; Othman M; Dughmosh R; Al-Mohanadi D; Al Sanousi A; Bashir M; Chagoury O; Taheri S; Abou-Samra AB
    Trials; 2022 Jun; 23(1):504. PubMed ID: 35710428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protocol: investigating the effectiveness and cost benefit of a lifestyle intervention targeting type 2 diabetes in Australia.
    Cloete L; Mitchell BG; Morton D
    BMC Endocr Disord; 2019 Jul; 19(1):74. PubMed ID: 31307434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of lifestyle intervention and meal replacement on glycaemic and body-weight control in Chinese subjects with impaired glucose regulation: a 1-year randomised controlled trial.
    Xu DF; Sun JQ; Chen M; Chen YQ; Xie H; Sun WJ; Lin YF; Jiang JJ; Sun W; Chen AF; Tang QR
    Br J Nutr; 2013 Feb; 109(3):487-92. PubMed ID: 23021205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale, design and study protocol of the randomised controlled trial: Diabetes Interventional Assessment of Slimming or Training tO Lessen Inconspicuous Cardiovascular Dysfunction (the DIASTOLIC study).
    Gulsin GS; Brady EM; Swarbrick DJ; Athithan L; Henson J; Baldry E; McAdam J; Marsh AM; Parke KS; Wormleighton JV; Levelt E; Yates T; Bodicoat D; Khunti K; Davies MJ; McCann GP
    BMJ Open; 2019 Mar; 9(3):e023207. PubMed ID: 30928925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.
    Gilis-Januszewska A; Lindström J; Tuomilehto J; Piwońska-Solska B; Topór-Mądry R; Szybiński Z; Peltonen M; Schwarz PE; Windak A; Hubalewska-Dydejczyk A
    BMC Public Health; 2017 Feb; 17(1):198. PubMed ID: 28202029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining how best to support overweight adults to adhere to lifestyle change: protocol for the SWIFT study.
    Taylor RW; Roy M; Jospe MR; Osborne HR; Meredith-Jones KJ; Williams SM; Brown RC
    BMC Public Health; 2015 Sep; 15():861. PubMed ID: 26341820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prevention Of WEight Regain in diabetes type 2 (POWER) study: the effectiveness of adding a combined psychological intervention to a very low calorie diet, design and pilot data of a randomized controlled trial.
    Berk KA; Buijks H; Ozcan B; Van't Spijker A; Busschbach JJ; Sijbrands EJ
    BMC Public Health; 2012 Nov; 12():1026. PubMed ID: 23176668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the DEXLIFE 'self-selected' lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial.
    O'Donoghue GM; Kennedy A; Andersen GS; Durkan E; Thybo T; Sinnott M; Nolan JJ; O'Gorman DJ
    Trials; 2015 Nov; 16():529. PubMed ID: 26581687
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.